InfaCare is an emerging specialty pharmaceutical company focused on the development and commercialization of proprietary pharmaceuticals for the neonatal and pediatric patient population.
Location: United States, Pennsylvania, Plymouth Meeting
Employees: 51-200
Total raised: $12.1M
Founded date: 2001
Investors 2
| Date | Name | Website |
| - | Park Lane ... | plvc.com/ |
| - | Atlas Vent... | atlasventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.07.2015 | - | $12.1M | - |
Mentions in press and media 2
| Date | Title | Description |
| 21.03.2013 | Pediatric drug developer with treatment for infantile jaundice could reduce readmissions | InfaCare’s drug Stanate was licensed from Rockefeller University. A heme oxygenase inhibitor, Stanate prevents the breakdown of heme in the body. It is designed to significantly reduce the body’s production of bilirubin over a six- to eight... |
| - | Pediatric drug developer with treatment for infantile jaundice could reduce readmissions | A pediatric drug developer has raised $3.55 million — the first tranche of a $21.5 million series C Round to advance its drug to treat infantile jaundice or hyperbilirubinemia through a phase 2 clinical trial. It initiated recruitment for t... |